We hope you will find items of interest in this section.  In writing and posting these materials, we are acting on our core company values:
  • Freely sharing public-domain scientific and technical knowledge,
  • Enabling our clients to be stronger and more knowledgeable through our interaction,
  • Reflecting our enthusiasm for the science behind our work.

​We hope you find these materials informative.  Don’t hesitate to call or email us if you have any questions, or suggestions on how we can make things better.

Meeting Notes

  • Bioequivalence BE of Ophthalmic Drug Products #1:  AAPS 2016

  • Bioequivalence BE of Ophthalmic Drug Products #2:  AAPS 2016

Posters and Presentations

  • Physical Properties of OTC Dry Eye Products in the US Market, ARVO 2008. 
  • Unique Rheological Properties of Alginate-based Systems for Dry Eye Therapy. 

  • Viscoelastic and Sedimentation Characterization of Loteprednol Etabonate Ophthalmic Gel, 0.5%.
  • A Comparative Evaluation of Lipid-based Formulations for Dry Eye Therapy.

Useful Articles

  • Considerations in Developing a Target Product Profile for Parenteral Pharmaceutical Products, William J. Lambert (2010) AAPS PharmSciTech, P 1476-148.​​